FDA Drug Recalls

Recalls / Class II

Class IID-0436-2015

Product

GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage Pharmaceuticals Inc. Eatontown, NJ 07724, NDC: 23155-116-01.

Brand name
Glipizide And Metformin Hcl
Generic name
Glipizide And Metformin Hcl
Active ingredients
Glipizide, Metformin Hydrochloride
Route
Oral
NDCs
23155-115, 23155-116, 23155-117
FDA application
ANDA078728
Affected lot / code info
Lot #:18020994, Expiry: October 2015; Lot #: 18021311, Expiry: November 2015.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification for unknown impurity.

Recalling firm

Firm
Heritage Pharmaceuticals, Inc.
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
12 Christopher Way Ste 300, N/A, Eatontown, New Jersey 07724-3331

Distribution

Quantity
6,816 Bottles
Distribution pattern
U.S. Nationwide including Puerto Rico.

Timeline

Recall initiated
2015-03-25
FDA classified
2015-04-07
Posted by FDA
2015-04-15
Terminated
2017-05-15
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0436-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.